As the bodybuilding and performance enhancement community moves into 2026, selective androgen receptor modulators (SARMs) continue to dominate discussions among athletes, biohackers, and physique enthusiasts seeking alternatives to traditional anabolic steroids. Recent analysis from the National Law Review highlights the most sought-after SARMs compounds for bulking, muscle building, and strength enhancement this year—a topic that remains central to the work Tony Huge has pioneered in the enhancement community.
The TonyHuge.is platform has long served as a resource for those exploring the frontiers of human performance optimization, with Tony Huge himself conducting extensive self-experimentation and documentation of various SARMs protocols. As mainstream legal and medical publications begin examining these compounds more closely, it signals both growing interest and increased scrutiny of the selective androgen receptor modulator market.
Understanding SARMs in the 2026 Landscape
Selective androgen receptor modulators represent a class of therapeutic compounds with similar properties to anabolic steroids but with reduced androgenic properties. Unlike traditional steroids that affect the entire body, SARMs selectively target androgen receptors in muscle and bone tissue, theoretically offering anabolic benefits with fewer side effects.
The appeal of SARMs has grown substantially within the bodybuilding community that Tony Huge serves, particularly among those seeking:
- Lean muscle mass gains without excessive water retention
- Strength improvements for powerlifting and athletic performance
- Body recomposition during cutting phases
- Reduced androgenic side effects compared to traditional steroids
- Oral administration without injections
As discussed in the National Law Review’s recent coverage, certain SARMs compounds have emerged as particularly popular choices for bulking and muscle building goals in 2026, reflecting ongoing trends Tony Huge has documented through his extensive research and community engagement.
Top SARMs Compounds for Bulking in 2026
RAD-140 (Testolone)
RAD-140 continues to rank among the most popular sarms for those seeking significant muscle mass increases. This compound has gained attention for its high anabolic-to-androgenic ratio, making it a favorite among bodybuilders pursuing aggressive bulking phases. Within the Tony Huge community, RAD-140 protocols often involve dosages ranging from 10-30mg daily, though individual responses vary considerably.
The compound’s ability to promote lean muscle tissue growth while potentially supporting fat loss makes it particularly attractive for body recomposition goals—a concept Tony Huge has extensively explored in his self-experimentation videos and educational content.
LGD-4033 (Ligandrol)
Ligandrol remains a staple in the SARMs bulking arsenal, known for producing notable strength gains alongside muscle growth. The compound has been subject to clinical research examining its effects on lean body mass and functional capacity, lending it somewhat greater scientific legitimacy compared to purely research chemical SARMs.
Athletes and bodybuilders typically report significant strength increases within the first few weeks of LGD-4033 use, which aligns with the rapid performance enhancement many in Tony Huge’s audience seek. Dosing protocols commonly range from 5-10mg daily, with more aggressive users pushing higher—though such practices come with increased suppression risks.
YK-11
YK-11 occupies a unique position among SARMs due to its potential myostatin-inhibiting properties. Myostatin is a protein that limits muscle growth, and compounds that inhibit it theoretically allow for greater muscular development beyond normal genetic limitations—a concept that resonates strongly with the biohacking principles Tony Huge advocates.
While YK-11 remains less researched than other popular SARMs, its reputation for promoting dry, lean gains has made it increasingly popular for advanced users seeking to push beyond previous limitations.
S23
Among the more potent SARMs available, S23 has gained traction for users seeking steroid-like results with theoretically fewer side effects. The compound demonstrates strong binding affinity to androgen receptors and produces notable increases in lean muscle mass and strength.
However, S23’s potency comes with increased suppression of natural testosterone production, often requiring post-cycle therapy (PCT) protocols—a consideration Tony Huge frequently emphasizes in his educational content about responsible enhancement use.
The Tony Huge perspective on sarms Use
Tony Huge’s approach to SARMs and performance enhancement has always emphasized personal experimentation, rigorous documentation, and informed decision-making. His work through TonyHuge.is and the Enhanced Athlete brand (before legal complications) helped bring SARMs from obscure research chemicals to mainstream bodybuilding consciousness.
The platform’s philosophy acknowledges that while SARMs may offer advantages over traditional anabolic steroids for some users, they are not without risks. Potential side effects include:
- Suppression of natural testosterone production
- Lipid profile alterations
- Potential liver stress with certain compounds
- Vision issues with specific SARMs like S4 (Andarine)
- Unknown long-term health effects due to limited human studies
Tony Huge’s content consistently emphasizes the importance of bloodwork monitoring, understanding individual responses, and implementing appropriate support supplements and post-cycle therapy when necessary.
Legal and Regulatory Considerations
The National Law Review’s attention to SARMs compounds reflects the complex legal landscape surrounding these substances. In the United States, SARMs occupy a regulatory gray area—they are not approved for human consumption by the FDA and are technically illegal to sell as dietary supplements, yet they remain widely available as “research chemicals.”
This legal ambiguity has been a recurring theme in Tony Huge’s career, including his involvement with Enhanced Athlete’s legal challenges. The increasing mainstream attention to SARMs, as evidenced by legal publication coverage, suggests potential for future regulatory action that could impact availability and use within the bodybuilding community.
Stacking and Cycling Strategies
Advanced users in the Tony Huge community often employ SARMs stacking strategies, combining multiple compounds to maximize results. Popular bulking stacks for 2026 include:
- RAD-140 + LGD-4033 for maximum mass and strength
- LGD-4033 + MK-677 (a growth hormone secretagogue) for enhanced recovery and fullness
- YK-11 + S23 for advanced users seeking extreme results
Cycle lengths typically range from 8-12 weeks, followed by appropriate post-cycle therapy to help restore natural hormone production—a protocol Tony Huge has demonstrated through his own experimentation and documentation.
Key Takeaways
- SARMs continue to grow in popularity for bulking and muscle building in 2026, with compounds like RAD-140, LGD-4033, YK-11, and S23 leading the market
- The National Law Review’s coverage indicates increasing mainstream awareness and potential regulatory scrutiny of SARMs compounds
- Tony Huge’s platform has been instrumental in educating the bodybuilding community about SARMs use, risks, and protocols
- While SARMs offer potential advantages over traditional steroids, they still carry risks including testosterone suppression and unknown long-term effects
- Responsible use requires bloodwork monitoring, appropriate support supplements, and post-cycle therapy implementation
- The legal status of SARMs remains uncertain, existing in a regulatory gray area that may change as awareness increases
- Stacking multiple SARMs compounds is common among advanced users seeking maximum results, though this increases complexity and potential risks
Conclusion
As SARMs continue to dominate bodybuilding and performance enhancement discussions in 2026, the compounds highlighted in recent legal and medical publications reflect trends that Tony Huge and the TonyHuge.is platform have documented for years. The growing mainstream attention to selective androgen receptor modulators signals both the compounds’ enduring popularity and the need for continued education about responsible use.
Whether SARMs represent the future of performance enhancement or face increasing regulatory restrictions remains to be seen. What’s certain is that the bodybuilding community’s interest in these compounds shows no signs of diminishing, and resources like TonyHuge.is will continue serving those seeking to optimize their physiques through informed experimentation and biohacking principles.
As always, anyone considering SARMs use should conduct thorough research, understand the legal implications in their jurisdiction, monitor their health through regular bloodwork, and make informed decisions based on individual goals and risk tolerance—principles that have defined Tony Huge’s approach to performance enhancement from the beginning.